Krishnan Krish S — SEC insider filings
SEC reporting owner CIK 1298709. 30 insider filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2021-03-02 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 201 legs across 23 filings — 875,000 shares, $127,139,416 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 48.
- Largest priced transaction: sale of 100,000 shares @ $70.50 ($7,050,000) in Krystal Biotech, Inc., filed 2021-12-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | President and CEO, Director, 10% owner | 30 | — | 201 legs · 875,000 sh · $127,139,416 | 48 |
Insider filings — Krishnan Krish S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 520 @ $354.54 · Sale (S): 2,029 @ $355.57 · Sale (S): 3,297 @ $356.37 · Sale (S): 3,981 @ $357.57 · Sale (S): 3,143 @ $358.42 · Sale (S): 3,357 @ $359.39 · +7 more | EDGAR |
| 2026-06-05 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 320 @ $300.75 · Sale (S): 640 @ $302.24 · Sale (S): 176 @ $303.17 · Sale (S): 544 @ $304.81 · Sale (S): 589 @ $306.33 · Sale (S): 11,461 @ $307.68 · +5 more | EDGAR |
| 2026-03-06 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 483 @ $257.31 · Sale (S): 470 @ $258.38 · Sale (S): 1,377 @ $259.87 · Sale (S): 3,128 @ $260.49 · Sale (S): 2,962 @ $261.41 · Sale (S): 2,380 @ $262.44 · +4 more | EDGAR |
| 2026-03-03 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,981 @ $275.64 · Option exercise (M): 26,250 @ $0 · Tax withholding (F): 11,942 @ $275.64 · Option exercise (M): 5,725 @ $0 · Tax withholding (F): 2,605 @ $275.64 · +9 more | EDGAR |
| 2025-12-05 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 956 @ $214.28 · Sale (S): 344 @ $215.48 · Sale (S): 1,600 @ $217.04 · Sale (S): 2,577 @ $218.72 · Sale (S): 5,693 @ $219.55 · Sale (S): 2,625 @ $220.34 · +11 more | EDGAR |
| 2025-07-16 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 13,400 @ $150.30 · Sale (S): 2,184 @ $150.68 · Sale (S): 900 @ $151.79 · Sale (S): 1,389 @ $150 · Sale (S): 13,335 @ $150.29 · Sale (S): 100 @ $151 · +3 more | EDGAR |
| 2025-07-11 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 200 @ $150.07 · Sale (S): 6,627 @ $150.22 · Sale (S): 300 @ $151.39 · Sale (S): 200 @ $150.14 · Sale (S): 6,500 @ $150.23 · Sale (S): 300 @ $151.39 | EDGAR |
| 2025-03-13 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 1,100 @ $175.83 · Sale (S): 4,944 @ $176.80 · Sale (S): 10,931 @ $177.62 · Sale (S): 6,769 @ $178.77 · Sale (S): 1,256 @ $179.57 · Sale (S): 1,639 @ $175.97 · +4 more | EDGAR |
| 2025-02-28 | 4 | Krystal Biotech, Inc. (KRYS) | Tax withholding (F): 4,721 @ $176.39 · Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,786 @ $179.25 · Option exercise (M): 8,750 @ $0 · Tax withholding (F): 4,050 @ $179.25 · Option exercise (M): 26,250 @ $0 · +11 more | EDGAR |
| 2024-12-13 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 6,302 @ $163.07 · Sale (S): 8,381 @ $163.91 · Sale (S): 4,909 @ $164.93 · Sale (S): 1,977 @ $165.82 · Sale (S): 923 @ $166.93 · Sale (S): 911 @ $169.65 · +11 more | EDGAR |
| 2024-09-13 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 3,957 @ $195.16 · Sale (S): 6,458 @ $195.72 · Sale (S): 1,696 @ $197.04 · Sale (S): 2,086 @ $198.08 · Sale (S): 4,008 @ $198.93 · Sale (S): 3,600 @ $200.15 · +9 more | EDGAR |
| 2024-06-11 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 1,100 @ $171.49 · Sale (S): 1,882 @ $172.21 · Sale (S): 1,318 @ $173.49 · Sale (S): 4,000 @ $174.83 · Sale (S): 4,550 @ $175.76 · Sale (S): 5,705 @ $176.68 · +10 more | EDGAR |
| 2024-03-11 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 2,146 @ $167.99 · Sale (S): 2,254 @ $168.88 · Sale (S): 5,109 @ $170.32 · Sale (S): 8,002 @ $170.93 · Sale (S): 2,816 @ $172.06 · Sale (S): 3,359 @ $173.09 · +8 more | EDGAR |
| 2024-03-01 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,785 @ $163.08 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $163.08 · Option exercise (M): 12,500 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-28 | 4 | Krystal Biotech, Inc. (KRYS) | Tax withholding (F): 3,791 @ $157 | EDGAR |
| 2023-12-12 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 4,400 @ $104.41 · Sale (S): 6,263 @ $105.50 · Sale (S): 14,237 @ $106.11 · Sale (S): 100 @ $107.66 · Sale (S): 2,854 @ $104.26 · Sale (S): 4,541 @ $105.06 · +2 more | EDGAR |
| 2023-09-12 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 5,008 @ $125.23 · Sale (S): 5,452 @ $126.17 · Sale (S): 1,873 @ $127.18 · Sale (S): 10,557 @ $128.37 · Sale (S): 2,110 @ $129.10 · Sale (S): 5,007 @ $125.23 · +4 more | EDGAR |
| 2023-06-02 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 18,884 @ $116.00 · Sale (S): 5,716 @ $116.95 · Sale (S): 400 @ $117.61 · Sale (S): 20,143 @ $115.98 · Sale (S): 4,557 @ $116.86 · Sale (S): 300 @ $117.57 | EDGAR |
| 2023-04-18 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 1,050 @ $85.55 · Sale (S): 4,298 @ $86.80 · Sale (S): 9,428 @ $87.41 · Sale (S): 9,724 @ $88.41 · Sale (S): 500 @ $89.12 · Sale (S): 1,050 @ $85.55 · +4 more | EDGAR |
| 2023-02-28 | 4 | Krystal Biotech, Inc. (KRYS) | Tax withholding (F): 4,350 @ $78.46 · Grant/award (A): 50,000 (derivative) @ $81.91 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 20,617 @ $80.70 · Sale (S): 1,186 @ $81.41 · Sale (S): 346 @ $82.71 · Sale (S): 20,617 @ $80.70 · Sale (S): 1,186 @ $81.41 · Sale (S): 345 @ $82.72 · +4 more | EDGAR |
| 2023-01-05 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 3,748 @ $80.08 · Sale (S): 3,938 @ $80.09 | EDGAR |
| 2023-01-03 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 7,447 @ $80.28 · Sale (S): 563 @ $81.11 · Sale (S): 7,484 @ $80.30 · Sale (S): 528 @ $81.10 · Sale (S): 1,700 @ $80.33 · Sale (S): 1,700 @ $80.33 | EDGAR |
| 2022-12-20 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 10,572 @ $80.10 · Sale (S): 10,527 @ $80.10 | EDGAR |
| 2022-11-28 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 4 @ $80.01 | EDGAR |
| 2022-11-10 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 966 @ $80.05 · Sale (S): 823 @ $80.04 | EDGAR |
| 2022-08-09 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 9,088 @ $80.24 · Sale (S): 13,058 @ $81.61 · Sale (S): 2,854 @ $82.19 · Sale (S): 8,992 @ $80.22 · Sale (S): 13,432 @ $81.62 · Sale (S): 2,576 @ $82.20 | EDGAR |
| 2022-03-01 | 4 | Krystal Biotech, Inc. (KRYS) | Tax withholding (F): 4,655 @ $62.50 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 100,000 @ $70.50 | EDGAR |
| 2021-03-02 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 40,800 · Grant/award (A): 61,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1298709 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs